★★★★★ 5
Hancock continues his exploration of good and evil -- Spoiler alert!
Format: Paperback
In this his second historical novel Graham Hancock continues his epic saga of good and evil, ancient civilizations, religions, the paranormal, and more. His recounting here of the warfare and perversity in the time of Cortes and Moctezuma is unflinching. One wonders at times what holds him in balance against the madness and carnage he depicts. There are romantic elements in the story, and a great innocence presented in the points of view of several young people of the time, and even in the personality of Cortes there are winsome elements presented, of which he must have held several in order to have become the inspired leader he became.
One fascination I found is the possibility that the evil demon god of the Mexicas (popularly but inaccurately known by most as the Aztecs), Hummingbird (I won't attempt the Mexica spelling here!) may simply have been another face of the Christian god Peter, not the Peter of the New Testament but the later Peter of the Inquisition and the New World conquest. And what is this demon god up to today?
I have been unable to find an update as to when Part Two of this story may be published. It does seem that GH, from a perusal of his fascinating Facebook page (see Author.GrahamHancock) has been working on it. For me it almost seems Part One is sufficient. I can fill in the outlines and projections from my own imagination.
But this book is a splendid attempt at finding a mass audience, toward gaining a readership of awakening souls to help renovate our present day logjam and remove the Moctezuma's of our time. But will we, as Cortez, find ourselves unable to truly create something better? For interested readers I recommend several writers -- Jim Marrs on the Nazis' continuation after WWII, also his "Alien Agenda," David Wilcock's (a good friend and interviewer of GH) and Wes Penre's works, much of which are free online. The only real revolution is in the human heart.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 5, 2014
02105-1/asset/8468e457-0c7f-4e4c-9b6d-2202dbefa9cb/main.assets/gr1_lrg.jpg "GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits")
